Special Issue "COVID-19: Focusing on Epidemiologic, Virologic, and Clinical Studies"
Deadline for manuscript submissions: 30 November 2020.
Interests: respiratory viruses; coronavirus; diagnostics; immune response; pathogenesis
Interests: viral infections; treatment; clinical impact; antiviral drugs; clinical picture
Special Issues and Collections in MDPI journals
We are all personally involved this very moment in history in the largest outbreak outside China of COVID-19; as such, I am positive that the more data we can gather and the more we know about this new clinical entity, the better equipped the scientific and medical community will be to fight back.
Thus, I believe that the readership of Microorganisms will greatly appreciate a collection of updated epidemiologic, virologic, and clinically-oriented papers on the many obscure aspects of this new pandemic.
In more detail, these are some of the most pressing questions in this topic:
1. Epidemiologic aspects: i) Is the infection kinetics the same in different countries? ii) What is the impact of different demographic composition on lethality and mortality rate? iii) What is the impact of different countermeasures on the SARS-CoV2 spread? v) Seroprevalence? vi) R0 and Rt in different countries?
2. Virology: i) Innovative molecular assays? ii) What is the impact of serologic assays on rapid diagnostics? iii) Drug susceptibility? iv) Genetic variability? v) Humoral and T-cell response kinetics?
3. Clinical: i) What is the Sars-CoV2 load and disease progression? ii) What is the effect of experimental drugs on virologic and clinical recovery? iii) NT levels and disease progression? iv) progression scores? v) COVID-associated clinical pictures? vi) risk factors for disease progression and death?
Prof. Fausto Baldanti
Prof. Dr. Raffaele Bruno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antiviral treatment
- clinical presentation
- molecular epidemiology
- risk factors
- prognostic parameters
- immune response